Loading stock data…
Astrana Health Inc. (ASTH)
$44.51+1.01 (+2.32%)
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Astrana Health, Inc. in the Healthcare sector is trading at $44.51 with a market capitalization of $1.8B. Wall Street consensus targets $46.00 (9 analysts), implying a +3.3% move over the next 12 months. The stock is currently near its 52-week high of $44.59, remaining 55.7% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $965.10M↑ | $950.53M↓ | $956.05M↑ | $654.81M↑ | $620.39M |
| Gross Profit | $105.74M↑ | $95.04M↓ | $97.19M↑ | $77.97M↑ | $71.33M |
| Operating Income | $28.53M↑ | $18.39M↓ | $19.21M↓ | $20.34M↓ | $20.58M |
| Net Income | $14.44M↑ | $6.00M↑ | $373,000↓ | $9.42M↑ | $6.69M |
Peer Comparison
JNJUNHPFE
Fundamentals
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.82B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
60.16
Beta
Defensive asset. Lower volatility than the S&P 500.
0.99
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
3.78%
Volume
Today's trading volume
1.96M
Recent News
Astrana Health (ASTH) Gets Upgraded by Barclays
Astrana Health, Inc. (NASDAQ:ASTH) is one of the best small cap stocks to buy for the long term. Astrana Health, Inc. (NASDAQ:ASTH) got upgraded to Overweight from Equal Weight by Barclays on May 26, with the firm lifting the price target on the stock to $50 from $37. It told investors in a research note […]
2 Russell 2000 Stocks with Exciting Potential and 1 We Ignore
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
2 Growth Stocks Set to Flourish and 1 Facing Headwinds
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.
A Look Back at Healthcare Technology for Providers Stocks’ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers industry, including Astrana Health (NASDAQ:ASTH) and its peers.
Is Astrana’s Q1 Results and AI Platform Push Altering The Investment Case For Astrana Health (ASTH)?
Earlier in May 2026, Astrana Health reported first-quarter revenue of US$965.1 million and net income of US$14.44 million, reaffirmed its 2026 revenue outlook, announced Chief Medical Officer Dinesh Kumar’s pending resignation, and named George Christides as Interim National Medical Director to oversee population health initiatives. Astrana Health and the Physician Association of California also revealed a collaboration that plugs independent primary care practices into Astrana’s in-house,...